Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | May 26, 2016 at 12:26 PM EDT

Ionis Pharmaceuticals Drops on Dismissed Study

Ionis Pharmaceuticals shares dropped severely after a less-than positive update on its IONIS-TTR Rx program.

Trey Thoelcke | May 26, 2016 at 11:35 AM EDT

How Medivation Shareholders May Lose Big by Poison Pill in Hostile Takeover Fight With Sanofi

Usually the term "hostile takeover" is an exaggeration, but Sanofi's takeover bid for Medivation actually looks pretty hostile, given that…

Chris Lange | May 26, 2016 at 11:05 AM EDT

OvaScience Prices Secondary Offering

OvaScience shares dropped early on Thursday after the company announced that it had priced its secondary offering of more than…

Trey Thoelcke | May 26, 2016 at 9:35 AM EDT

Capital Infusions Are More Evidence of a Biotech Turnaround

Here are four biotech companies that have just either closed fresh financing rounds or issued IPOs that exceeded price expectations.

Jon C. Ogg | May 26, 2016 at 8:10 AM EDT

7 Companies in the Fight to Defeat the Zika Virus

Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small…

Chris Lange | May 25, 2016 at 11:55 AM EDT

Why Sarepta’s PDUFA Delay Is a Good Thing

Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares saw a handy gain on Wednesday following an analyst upgrade from Janney Montgomery Scott.

Chris Lange | May 25, 2016 at 11:45 AM EDT

Cellectar Wins Big on New Patent

Cellectar Biosciences watched its shares skyrocket on Wednesday morning following the announcement that it has obtained a patent that covers…

Lee Jackson | May 25, 2016 at 10:05 AM EDT

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue…

Chris Lange | May 25, 2016 at 9:40 AM EDT

5 Major Clinical Trial Results Coming Up

24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in…

Chris Lange | May 25, 2016 at 8:20 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | May 25, 2016 at 8:15 AM EDT

Short Sellers Take Mixed Stance on Major Pharma

The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Jon C. Ogg | May 24, 2016 at 4:48 PM EDT

PDL’s Next Acquisition Target Focus Is on Hypertension

PDL BioPharma Inc. (NASDAQ: PDLI) has now shown where its next revenue stream will be coming from. The company announced…

Jon C. Ogg | May 24, 2016 at 4:27 PM EDT

Selecta Biosciences Files for IPO: Targeting Gout

Selecta Biosciences has filed its paperwork with the Securities and Exchange Commission to conduct an initial public offering (IPO) ahead.…

Chris Lange | May 24, 2016 at 10:20 AM EDT

Nant Health Announces Potential Pricing for IPO

Nant Health expects to price more than 6 million shares in the range of $12.50 to $15.50 for an initial…

Jon C. Ogg | May 23, 2016 at 12:35 PM EDT

Are There More Insurance Giant Merger Risks?

Leerink issued a report telegraphing that health insurance mergers might be more at risk and that one is more likely…

1 … 209 210 211 212 213 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Ionis Pharmaceuticals Drops on Dismissed Study

How Medivation Shareholders May Lose Big by Poison Pill in Hostile Takeover Fight With Sanofi

OvaScience Prices Secondary Offering

Capital Infusions Are More Evidence of a Biotech Turnaround

7 Companies in the Fight to Defeat the Zika Virus

Why Sarepta’s PDUFA Delay Is a Good Thing

Cellectar Wins Big on New Patent

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

5 Major Clinical Trial Results Coming Up

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Take Mixed Stance on Major Pharma

PDL’s Next Acquisition Target Focus Is on Hypertension

Selecta Biosciences Files for IPO: Targeting Gout

Nant Health Announces Potential Pricing for IPO

Are There More Insurance Giant Merger Risks?

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Ionis Pharmaceuticals Drops on Dismissed Study

How Medivation Shareholders May Lose Big by Poison Pill in Hostile Takeover Fight With Sanofi

OvaScience Prices Secondary Offering

Capital Infusions Are More Evidence of a Biotech Turnaround

7 Companies in the Fight to Defeat the Zika Virus

Why Sarepta’s PDUFA Delay Is a Good Thing

Cellectar Wins Big on New Patent

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

5 Major Clinical Trial Results Coming Up

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Take Mixed Stance on Major Pharma

PDL’s Next Acquisition Target Focus Is on Hypertension

Selecta Biosciences Files for IPO: Targeting Gout

Nant Health Announces Potential Pricing for IPO

Are There More Insurance Giant Merger Risks?

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check